
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a veterinarian's order for one animal patient. Not FDA-approved.
No FDA-approved animal drug contains gabapentin; Animal Drugs@FDA returns no gabapentin products. Gabapentin is an FDA-approved human medicine (Neurontin and generics) labeled for nerve pain after shingles and as add-on treatment for partial-onset seizures in people. The Merck Veterinary Manual describes its use by veterinarians as an add-on seizure medicine in dogs and cats, which is not an FDA-approved use in animals. Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The Merck Veterinary Manual says sleepiness and wobbliness are the most common side effects in dogs, and that cats can become overly sedated. Gabapentin leaves the body through the kidneys, so animals with kidney disease may need adjustments from the veterinarian. The human Neurontin oral solution contains xylitol, a sweetener Merck says can be toxic and cause liver failure; FDA warns xylitol poisoning can kill dogs and lists liquid medicines among products that may contain it. Never give a pet a human gabapentin liquid unless your veterinarian approves that exact product. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
With no approved animal product, gabapentin use in companion animals is extralabel use of an approved human drug, permitted in nonfood-producing animal practice under 21 CFR 530.30 except when public health is threatened; compounding from an approved human product falls under 530.13(b); 530.13(a) excludes compounding from bulk. Gabapentin is on FDA's GFI #256 office stock list as an oral suspension for dogs and cats, with FDA noting no approved product at that strength safe for both (updated 10/05/2026). Merck notes exclusive renal excretion and that the commercially available liquid formulation contains xylitol; the NEURONTIN oral solution label lists xylitol as an inactive ingredient. No FDA CVM safety communication was found.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth